ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Electric Blankets May Be Risk Factor In Childhood Cancer

May 18, 1990

C. Gordon Zubrod, 84, Dies, Led Chemotherapy Research, Built Cooperative Group System

January 29, 1999

NCI Intends To Extend OSCC Two More Years

October 3, 1986

Includes January Business & Regulatory Report (8-page issue).

January 31, 2003